Stock Research for ABT

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ABT Stock Chart & Research Data

The ABT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ABT Due diligence Resources & Stock Charts

The ABT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ABT Detailed Price Forecast - CNN Money CNN View ABT Detailed Summary - Google Finance
Yahoo View ABT Detailed Summary - Yahoo! Finance Zacks View ABT Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ABT Trends & Analysis - Trade-Ideas Barrons View ABT Major Holders - Barrons
NASDAQ View ABT Call Transcripts - NASDAQ Seeking View ABT Breaking News & Analysis - Seeking Alpha
Spotlight View ABT Annual Report - CompanySpotlight.com OTC Report View ABT OTC Short Report - OTCShortReport.com
TradeKing View ABT Fundamentals - TradeKing Charts View ABT SEC Filings - Bar Chart
WSJ View Historical Prices for ABT - The WSJ Morningstar View Performance/Total Return for ABT - Morningstar
MarketWatch View the Analyst Estimates for ABT - MarketWatch CNBC View the Earnings History for ABT - CNBC
StockMarketWatch View the ABT Earnings - StockMarketWatch MacroAxis View ABT Buy or Sell Recommendations - MacroAxis
Bullish View the ABT Bullish Patterns - American Bulls Short Pains View ABT Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ABT Stock Mentions - StockTwits PennyStocks View ABT Stock Mentions - PennyStockTweets
Twitter View ABT Stock Mentions - Twitter Invest Hub View ABT Investment Forum News - Investor Hub
Yahoo View ABT Stock Mentions - Yahoo! Message Board Seeking Alpha View ABT Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for ABT - SECform4.com Insider Cow View Insider Transactions for ABT - Insider Cow
CNBC View ABT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ABT - OTC Markets
Yahoo View Insider Transactions for ABT - Yahoo! Finance NASDAQ View Institutional Holdings for ABT - NASDAQ


Stock Charts

FinViz View ABT Stock Insight & Charts - FinViz.com StockCharts View ABT Investment Charts - StockCharts.com
BarChart View ABT Stock Overview & Charts - BarChart Trading View View ABT User Generated Charts - Trading View


Latest Financial News for ABT

Top Analyst Reports for Goldman Sachs, Abbott & Altria
Posted on Friday April 20, 2018

Top Analyst Reports for Goldman Sachs, Abbott & Altria


Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023
Posted on Friday April 20, 2018

LONDON, April 20, 2018 /PRNewswire/ -- Abbott (ABT) and the World Marathon Majors today announced the renewal of Abbott's title sponsorship. Abbott became the first title sponsor of the series in 2015. "At Abbott, we create life-changing technologies that help people live fully and accomplish their personal goals – like running a marathon," said Elaine Leavenworth, senior vice president, chief marketing and external affairs officer, Abbott.


Aortic Stenosis, And The Race To Catch Edwards Lifesciences' Heart Valves
Posted on Thursday April 19, 2018

Edwards Lifesciences, Medtronic, Boston Scientific and Abbott Laboratories are duking it out for a share of the fast-growing heart-valve replacement market.


Abbott Shares Topple After Pharma Unit Struggles In First Quarter
Posted on Wednesday April 18, 2018

Shares of Abbott Laboratories dipped early Wednesday — despite its broad first-quarter beat — on pharmaceutical sales that lagged Wall Street's expectations by nearly 4%.


Enter a stock symbol to view the stock details.